Paid Clinical Trials - 82,000 Members & Growing

  • Paid Clinical Trials
  • About Us
  • Auto-Updates
  • FAQ's
  • Quick Start Guide
www.GlobalTestMarket.com

 

Find Paid Clinical Trials Join Paid Clinical Trials ...

PaidClinicalTrials.org is a registry of compensated and uncompensated, federally and privately supported clinical trials conducted in the United States and around the world. Here you will find information about a trial's purpose, who may participate, locations, and phone numbers.

 

Find Paid Clinical Trials Clinical Trial Seekers - PCT is a public service, sponsor supported, clinical trial database that may be accessed by the general public at no charge in accordance with our terms of service use.

Clinical trials are added and removed each day on a 30 day rotation. For accuracy - We only list clinical trials that have been reported to these government agencies in the last 30 days:

 

U.S. National Library of Medicine,
U.S. Department of Health & Human Services
U.S. National Institutes of health Services.







Paid Clinical Trials - Auto Update Service

If you would like to receive timely and important notifications about new clinical trials in your area please fill out this short form. There is never any cost for our notification services. We value your privacy, your email address and member information is NEVER shared!

*  Your Email Address:
*  Preferred Format:
    Title:
    First Name:
    Country:
    State (US):
    City (UK):
    Territory (AU):

Tips for Finding Clinical Trials

 

One of the toughest and most-time consuming parts for medical research staff conducting the clinical trials is actually finding volunteers willing to participate. Research staff are looking for you! There are numerous ways to identify clinical trials looking for healthy human volunteers.

 

Trials are actively conducted by hospitals, universities, foundations, and contract research organizations (CROs, firms that conduct studies for big pharmaceutical and biotechnology companies). According to CISCRP, nearly 40% of these clinical trials can be learned about through media such as tv, radio, or printed ads. While finding studies through tv and radio ads might be difficult, you can actively scour the wanted section of your local newspapers to find trials.

Most local research clinics run ads for volunteers in the local newspaper, employment papers, on TV, and on the radio. They also post ads on Craigslist and on their own websites. Call them up as soon as you see something of interest. If the study is no longer recruiting volunteers, they might enter you in there database for future study participation.

 

Look up local research clinics in your phone book and ask (a) if they have any studies openly recruiting healthy volunteers and (b) if you could be entered into their volunteer database.

College campuses and major universities with research hospitals are also great places to find clinical trial. Schools of medicine, dentistry, and nursing, along with departments of psychology, sociology, and communications, at local universities, are always looking for willing volunteers for their experiments. Perform an internet search for the hospitals, schools, and departments on nearby campuses, then look for any section concerning clinical trials or research volunteers.


When searching for clinical trials on our website you will click on a Clinical Trial Information sheet like this example. Find Paid Clinical Trials Example Information Sheet. The first thing you should do is to see if the clinical trial is right for you. You can do this by quickly scanning the headings of the information sheet. These headings are highlighted on the left by blue icons as follows:


  >> Status of the Clinical Trial (This will appear at the top in red or green)


Purpose - This will briefly let you know about the clinical trial and how it is conducted.


Eligibility - This tells you age, gender and health status information. If you do not meet these eligibility requirement you should move to another clinical trial.


Contacts and Locations - This will list the locations the clinical trial is being conducted and it will usually list the contact person to call. Note - Even if your location is not listed you should call the clinical trial investigator. Sometimes their locations have not been updated or they are willing to pay time and travel expenses.


More Information - This will often give alternative contact people and other pertinent information about the trial.

These headings appear on the left side of the information sheet and are fairly self explanatory. Doing this will help you to quickly evaluate if the clinical trial is right for you.

 


 

Paid Clinical Trials Searching Tips

 

Paid Clinical Trials Check the Conditions Category - If you only search the "Locations" directory you are missing out on a lot of clinical trials. Trials that are listed by "Condition" usually have multiple locations and can add new locations as the study moves forward.

 

Paid Clinical Trials Register Your Profile with us. - You can post your location and condition in our personal clinical trials directory for FREE. This helps the research recruiters find you when the right trial becomes available. Register for Clinical Trials Here.

 

Paid Clinical Trials Call the Clinical Trial Recruiters - At the bottom of all the information sheets you will see a "Contact Information" heading. Many clinical trials can be conducted in remote locations and the recruiters can help you.

 

Paid Clinical Trials Subscribe to our Auto Update Service - By subscribing to our Auto Update Service you will receive automated emails informing you when new trials have opened in your area.

Sponsored Links







  • Condition:   Speech Sound Disorder
    Interventions:   Behavioral: Biofeedback-ultrasound;   Behavioral: Biofeedback--visual-acoustic;   Behavioral: Traditional articulation treatment
    Sponsors:   New York University;   Syracuse University;   Montclair State University
    Recruiting

  • Conditions:   Concussion;   Mild Traumatic Brain Injury;   Cognitive Communication Disorder
    Intervention:   Other: Early cognitive-communication therapy
    Sponsors:   Northern Arizona University;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Conditions:   Mother-child Relations;   Parenting;   Parent Child Abuse;   Family Conflict;   Parental Stress;   Family Relations;   Childhood Disorder of Social Functioning, Unspecified
    Intervention:   Other: Therapeutic intervention
    Sponsors:   Boston Medical Center;   The New School for Social Research;   Family and Youth Services Bureau , DHHS
    Recruiting

  • Condition:   Speech Sound Disorder
    Interventions:   Behavioral: Biofeedback--visual-acoustic;   Behavioral: Biofeedback-ultrasound
    Sponsors:   New York University;   Syracuse University;   Montclair State University
    Recruiting

  • Conditions:   Critical Illness;   Communication Disabilities
    Interventions:   Behavioral: EMPOWER;   Other: Enhanced Usual Care
    Sponsors:   Weill Medical College of Cornell University;   New York Hospital Queens;   Memorial Sloan Kettering Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Autism;   Autism Spectrum Disorder;   Nonverbal Learning Disability
    Interventions:   Drug: Memantine Hydrochloride;   Drug: Placebo
    Sponsor:   Massachusetts General Hospital
    Not yet recruiting

  • Condition:   Aphasia
    Interventions:   Behavioral: Language therapy;   Behavioral: Background Music;   Behavioral: Aerobic Exercise
    Sponsor:   NYU Langone Health
    Recruiting

  • Condition:   Speech Sound Disorder
    Interventions:   Behavioral: Speech Production Treatment.;   Behavioral: Speech Production + Speech Perception Treatment.
    Sponsors:   Idaho State University;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Condition:   Specific Language Impairment
    Interventions:   Behavioral: Science + Phonological Awareness;   Behavioral: Science + Grammar Intervention;   Behavioral: Science + Vocabulary Intervention
    Sponsors:   Father Flanagan’s Boys’ Home;   University of Delaware;   University of Iowa
    Recruiting

  • Condition:   Language Development Disorders
    Intervention:   Behavioral: behavioral training
    Sponsor:   University of Delaware
    Recruiting

  • Condition:   Language Development Disorders
    Intervention:   Behavioral: Interactive storybook reading
    Sponsors:   University of Kansas;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Condition:   Developmental Language Disorder
    Intervention:   Behavioral: the Enhanced Milieu Teaching-Sentence Focus
    Sponsors:   Northwestern University;   Vanderbilt University;   University of Illinois at Urbana-Champaign
    Not yet recruiting

  • Conditions:   FOXP1;   Mental Retardation With Language Impairment and With or Without Autistic Features;   Autism Spectrum Disorder
    Intervention:  
    Sponsors:   Icahn School of Medicine at Mount Sinai;   The Seaver Foundation;   Autism Science Foundation;   Research Foundation for Mental Hygiene, Inc.
    Recruiting

  • Conditions:   Amyotrophic Lateral Sclerosis;   Parkinson Disease
    Intervention:   Behavioral: Phonetic complexity effects on speech motor performance
    Sponsors:   University of Missouri-Columbia;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Condition:   Primary Progressive Aphasia
    Intervention:   Behavioral: Evidence-Based Treatment
    Sponsors:   Northwestern University;   National Institute on Aging (NIA)
    Recruiting

  • Conditions:   Classic Galactosemia;   Speech Disorders in Children;   Language Disorders in Children
    Intervention:   Behavioral: Babble Boot Camp
    Sponsors:   Arizona State University;   Washington State University
    Recruiting

  • Conditions:   Non-verbal Learning Disorder;   Autism Spectrum Disorder;   Autism
    Interventions:   Drug: Open-label Treatment with Omega-3 Fatty Acids + Inositol;   Drug: Open-label Treatment with N-Acetyl Cysteine
    Sponsors:   Massachusetts General Hospital;   Demarest Lloyd Jr. Foundation
    Not yet recruiting

  • Condition:   Reading Disability
    Intervention:   Behavioral: preK
    Sponsors:   University of Washington;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Condition:   Reading Disability
    Intervention:   Behavioral: Reading Tutoring
    Sponsors:   Vanderbilt University;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Conditions:   Speech Sound Disorder;   Phonology Disorder;   Phonology Impairment;   Phonological Disorder;   Articulation Disorders in Children;   Developmental Phonological Disorder;   Speech Disorders;   Speech Delay;   Articulation Disorders, Developmental
    Interventions:   Behavioral: articulation therapy;   Behavioral: phonologic treatment
    Sponsor:   University of Wyoming
    Recruiting

  • Conditions:   Autism Spectrum Disorder;   Moderate Language Delay
    Interventions:   Behavioral: Direct Instruction-Language for Learning (DI-LL);   Behavioral: Treatment as Usual
    Sponsor:   Emory University
    Recruiting

  • Conditions:   Primary Progressive Aphasia;   PPA
    Interventions:   Device: Active tDCS plus Speech-Language Therapy;   Device: Sham tDCS plus Speech-Language Therapy
    Sponsor:   Johns Hopkins University
    Recruiting

  • Condition:   Niemann-Pick Disease, Type C1
    Intervention:   Drug: Hydroxypropyl-β-cyclodextrin
    Sponsor:   CTD Holdings, Inc.
    Recruiting

  • Condition:   Niemann-Pick Disease, Type C1
    Intervention:   Drug: VTS-270
    Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Condition:   Primary Progressive Aphasia
    Interventions:   Device: HD-tDCS;   Device: Sham
    Sponsor:   Medical College of Wisconsin
    Not yet recruiting

  • Condition:   Niemann-Pick Disease, Type C
    Intervention:   Drug: 2-Hydroxypropyl-Beta-Cyclodextrin
    Sponsors:   Washington University School of Medicine;   Johns Hopkins University;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Conditions:   Language Development Disorders;   Autism Spectrum Disorder
    Intervention:   Behavioral: Parent Early Language Stimulation Training
    Sponsor:   Temple University
    Recruiting

  • Conditions:   Aphasia;   Stroke
    Interventions:   Drug: Escitalopram 10mg;   Drug: Placebo;   Behavioral: Computer-delivered naming treatment
    Sponsors:   Johns Hopkins University;   University of South Carolina;   Medical University of South Carolina;   University of California, Irvine
    Not yet recruiting

  • Condition:   Aphasia
    Interventions:   Device: Offline tDCS-before therapy;   Device: Sham tDCS;   Device: Offline tDCS-after therapy;   Device: Online tDCS
    Sponsors:   Shirley Ryan AbilityLab;   National Institute on Disability, Independent Living, and Rehabilitation Research
    Recruiting

  • Conditions:   Logopenic Variant Primary Progressive Aphasia;   Non-Fluent Primary Progressive Aphasia
    Interventions:   Device: Active rTMS;   Device: SHAM rTMS
    Sponsors:   Brigham and Women's Hospital;   Massachusetts General Hospital
    Recruiting

  • Condition:   Aphasia
    Interventions:   Device: Active TMS;   Device: Sham TMS;   Behavioral: CILT
    Sponsors:   H. Branch Coslett;   National Institutes of Health (NIH);   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Condition:   Strategy Training
    Intervention:   Behavioral: Strategy Training
    Sponsors:   University of Pittsburgh;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Conditions:   MLD;   Krabbe Disease;   ALD;   MPS I;   MPS II;   MPS III;   Vanishing White Matter Disease;   GM3 Gangliosidosis;   PKAN;   Tay-Sachs Disease;   NP Deficiency;   Osteopetrosis;   Alpha-Mannosidosis;   Sandhoff Disease;   Niemann-Pick Diseases;   MPS IV;   Gaucher Disease;   GAN;   GM1 Gangliosidoses;   Morquio Disease;   S-Adenosylhomocysteine Hydrolase Deficiency;   Batten Disease;   Pelizaeus-Merzbacher Disease;   Leukodystrophy;   Lysosomal Storage Diseases;   Purine Nucleoside Phosphorylase Deficiency;   Multiple Sulfatase Deficiency Disease
    Interventions:   Other: Palliative Care;   Biological: Hematopoetic Stem Cell Transplantation
    Sponsor:   University of Pittsburgh
    Recruiting

  • Condition:   Aphasia
    Intervention:   Behavioral: Abstract Semantic Association Network Training (AbSANT)
    Sponsor:   Penn State University
    Recruiting

  • Condition:   Aphasia
    Intervention:   Device: transcranial direct current stimulation
    Sponsor:   University of Michigan
    Recruiting

  • Conditions:   Apraxia of Speech;   Non-fluent Aphasia;   Primary Progressive Aphasia;   Primary Progressive Nonfluent Aphasia
    Intervention:   Diagnostic Test: Testing protocol for the study
    Sponsor:   Mayo Clinic
    Recruiting

  • Condition:   Stuttering, Developmental
    Interventions:   Device: Anodal tDCS;   Behavioral: Fluency training;   Device: Sham tDCS
    Sponsor:   University of Michigan
    Recruiting

  • Conditions:   Aging;   Aphasia
    Interventions:   Behavioral: Moderate Intensity Exercise;   Behavioral: Gentle Stretching
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Condition:   Primary Progressive Aphasia
    Intervention:   Device: transcranial direct current stimulation
    Sponsor:   University of Pennsylvania
    Recruiting

  • Condition:   Aphasia, Acquired
    Intervention:   Device: Transcranial Magnetic Stimulation
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Frontotemporal Lobar Degeneration;   Amytrophic Lateral Sclerosis;   Progressive Supranuclear Palsy
    Intervention:  
    Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting

  • Conditions:   Primary Progressive Aphasia;   MCI;   FTD
    Interventions:   Device: Active tDCS plus Speech-Language Therapy;   Device: Sham plus Speech-Language Therapy
    Sponsors:   Johns Hopkins University;   National Institutes of Health (NIH);   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Condition:   Stroke
    Interventions:   Device: Anodal or Cathodal tDCS;   Device: Sham;   Behavioral: Computerized naming therapy
    Sponsors:   Johns Hopkins University;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Conditions:   Dementia;   Alzheimer Disease;   Circadian Rhythm Disorders;   Circadian Rhythm Sleep Disorder;   Insomnia;   Hypersomnia;   Cognitive Impairment;   Cognitive Decline;   Mild Cognitive Impairment;   Frontotemporal Dementia;   Neurocognitive Disorders;   Vascular Dementia;   Sleep Disorder;   Memory Impairment
    Interventions:   Behavioral: Attention-Control Condition;   Behavioral: Timed Activity Intervention
    Sponsor:   University of Pennsylvania
    Recruiting

  • Conditions:   Stroke;   Aphasia
    Intervention:   Device: Transcranial Magnetic Stimulation
    Sponsor:   University of Pennsylvania
    Recruiting

  • Conditions:   Atypical Alzheimer's Disease;   Logopenic Progressive Aphasia (LPA);   Posterior Cortical Atrophy (PCA)
    Interventions:   Drug: F-18 AV 1451;   Drug: C-11 PiB
    Sponsor:   Mayo Clinic
    Recruiting

  • Conditions:   Specific Learning Disorder (MeSH Unique ID: D000067559);   Dyslexia (MeSH Unique ID: D004410);   Conduct Disorder (MeSH Unique ID: D019955)
    Intervention:   Behavioral: Strategies Enhancing Reading in Older Underperf. Students
    Sponsors:   Baylor College of Medicine;   University of Houston;   Harris County Juvenile Probation Department (HCJPD);   Connecticut Court Support Services Division (CSSD);   MindTrust Labs, LLC
    Recruiting

  • Conditions:   Alzheimer Disease, Early Onset;   Alzheimer Disease;   Alzheimer Disease, Late Onset;   Dementia, Alzheimer Type;   Logopenic Progressive Aphasia;   Primary Progressive Aphasia;   Visuospatial/Perceptual Abilities;   Posterior Cortical Atrophy;   Executive Dysfunction;   Corticobasal Degeneration;   Ideomotor Apraxia
    Intervention:  
    Sponsors:   University of California, Los Angeles;   National Institute on Aging (NIA);   University of Southern California
    Recruiting

  • Conditions:   Ataxia;   Dystonia;   Parkinson's Disease;   Amyotrophic Lateral Sclerosis;   Corticobasal Degeneration;   Multiple System Atrophy;   Alzheimer's Disease;   Lewy Body Dementia;   Parkinson Disease-Dementia;   Dentatorubral-pallidoluysian Atrophy;   Creutzfeldt-Jakob Disease and Fatal Familial Insomnia;   Fragile X-associated Tremor/Ataxia Syndrome;   Krabbe's Disease;   Niemann-Pick Disease, Type C;   Neuronal Ceroid Lipofuscinosis
    Intervention:  
    Sponsor:   National Institute on Aging (NIA)
    Recruiting

  • Conditions:   Language Development Disorders;   Down Syndrome;   Child Language
    Intervention:   Behavioral: Semantic cues (perform action), syntactic cues (sentence frame), or combined semantic and syntactic cues
    Sponsor:   Vanderbilt University Medical Center
    Recruiting

  • Conditions:   Learning Disorders;   Dyslexia
    Intervention:   Behavioral: RISE Intervention
    Sponsors:   University of Houston;   University of Texas at Austin;   The University of Texas Health Science Center, Houston;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Conditions:   Dementia;   Alzheimer's Disease;   Frontotemporal Dementia
    Interventions:   Device: In-home technology;   Device: Limited in-home technology
    Sponsors:   University of California, Berkeley;   University of California, San Francisco;   People Power Company;   National Institute on Aging (NIA)
    Recruiting

  • Condition:   Primary Progressive Aphasia With Suspected Alzheimer's Disease
    Interventions:   Drug: 18F-AV-1451;   Device: PET
    Sponsors:   Northwestern University;   National Institute on Aging (NIA)
    Recruiting

  • Conditions:   PPA;   Non-fluent Aphasia;   Apraxia of Speech;   Primary Progressive Non-fluent Aphasia;   Primary Progressive Aphasia
    Intervention:   Drug: AV-1451
    Sponsor:   Mayo Clinic
    Recruiting

  • Conditions:   Adrenoleukodystrophy;   Batten Disease;   Mucopolysaccharidosis II;   Leukodystrophy, Globoid Cell;   Leukodystrophy, Metachromatic;   Neimann Pick Disease;   Pelizaeus-Merzbacher Disease;   Sandhoff Disease;   Tay-Sachs Disease;   Brain Diseases, Metabolic, Inborn;   Alpha-Mannosidosis;   Sanfilippo Mucopolysaccharidoses
    Intervention:   Biological: DUOC-01
    Sponsors:   Joanne Kurtzberg, MD;   The Marcus Foundation
    Recruiting

  • Conditions:   Alzheimer Disease;   Alzheimer Dementia;   Frontotemporal Dementia
    Interventions:   Device: Spectral-Domain Optical Coherence Tomography (SD-OCT);   Device: Magnetic Resonance Imaging (MRI);   Device: Positron Emission Tomography (PET);   Diagnostic Test: Comprehensive Ophthalmic Examination;   Device: Fundus Photography
    Sponsor:   University of Michigan
    Recruiting

  • Conditions:   Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   PLS;   Motor Neuron Disease;   Lou Gehrigs Disease;   Familial Disease;   Amyotrophic Lateral Sclerosis, Sporadic;   Muscular Dystrophy;   Miyoshi Myopathy
    Intervention:  
    Sponsors:   University of Massachusetts, Worcester;   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting

  • Conditions:   Primary Progressive Aphasia;   Mild Cognitive Impairment;   Frontotemporal Dementia
    Interventions:   Device: Anodal tDCS + vSTM therapy;   Device: Sham + short-term memory therapy
    Sponsors:   Johns Hopkins University;   National Institutes of Health (NIH);   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Not yet recruiting

  • Conditions:   Stroke;   Aphasia
    Intervention:   Device: tDCS
    Sponsor:   Casa Colina Hospital and Centers for Healthcare
    Recruiting

  • Conditions:   Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   ALS-Frontotemporal Dementia;   Primary Lateral Sclerosis;   Progressive Muscular Atrophy
    Intervention:  
    Sponsors:   University of Miami;   National Institutes of Health (NIH);   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting

  • Conditions:   Primary Tauopathies;   Corticobasal Degeneration Syndrome;   Frontotemporal Lobar Degeneration With Tau Inclusions;   MAPT Mutation Carriers, Symptomatic;   Traumatic Encephalopathy Syndrome;   Nonfluent Aphasia, Progressive
    Interventions:   Drug: BIIB092;   Other: Placebo
    Sponsor:   University of California, San Francisco
    Recruiting

  • Conditions:   Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration (CBD);   Frontotemporal Dementia (FTD MAPT Mutation)
    Intervention:   Other: 13C6 Leucine
    Sponsors:   Washington University School of Medicine;   Association of Frontotemporal Degeneration;   Tau Consortium
    Recruiting

  • Condition:   Primary Progressive Aphasia
    Intervention:  
    Sponsors:   Northwestern University;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Conditions:   Neurofibromatosis Type 1;   Learning Disability;   Reading Disability;   NF1
    Interventions:   Drug: Lovastatin;   Behavioral: reading tutoring intervention;   Drug: Placebo Oral Tablet;   Behavioral: Other Academic "sham" tutoring
    Sponsors:   Vanderbilt University;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Condition:   Aphasia
    Interventions:   Behavioral: Texting Intervention (T-WRITE);   Behavioral: HandWriting Intervention (ORLA+WTG)
    Sponsors:   Shirley Ryan AbilityLab;   James Madison University
    Recruiting

  • Condition:   Reading Problem
    Interventions:   Behavioral: Reading;   Behavioral: Mindset;   Behavioral: Reading Embedded with Mindset;   Behavioral: Business as Usual
    Sponsors:   Vanderbilt University;   Southern Methodist University;   Florida State University
    Recruiting

  • Condition:   Stroke and Aphasia
    Intervention:   Behavioral: Communal singing
    Sponsor:   Icahn School of Medicine at Mount Sinai
    Recruiting

  • Condition:   Aphasia
    Intervention:  
    Sponsors:   Temple University;   University of Washington
    Recruiting

  • Conditions:   Aphasia;   Stroke;   Cerebrovascular Accident;   Apoplexy;   Cerebral Infarction
    Interventions:   Behavioral: Melodic Intonation Therapy;   Behavioral: Speech-Repetition-Therapy
    Sponsors:   Beth Israel Deaconess Medical Center;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Condition:   Aphasia
    Intervention:   Behavioral: Multimodality information comprehension
    Sponsors:   Miami University;   Duquesne University;   University of Arizona;   University of Nebraska Lincoln
    Recruiting

  • Condition:   Chronic Aphasia
    Interventions:   Device: HD-tDCS (Soterix Medical, Active);   Device: HD-tDCS (Soterix Medical, Sham)
    Sponsors:   Soterix Medical;   National Institute of Neurological Disorders and Stroke (NINDS);   Georgetown University;   University of North Carolina, Chapel Hill;   The City College of New York;   Medstar Health Research Institute;   University of South Carolina
    Recruiting

  • Condition:   Niemann-Pick Disease, Type C1
    Intervention:   Drug: Hydroxypropyl-beta-cyclodextrin
    Sponsor:   CTD Holdings, Inc.
    Recruiting

  • Conditions:   Aphasia;   CVA;   Apraxia of Speech
    Intervention:   Behavioral: Sound Production Treatment (SPT)
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Down Syndrome;   Speech and Language Disorder;   Speech Disorders in Children;   Speech Intelligibility;   Speech Sound Disorder
    Interventions:   Behavioral: AAC Generative Language Intervention;   Behavioral: Standard of Care / Business as Usual
    Sponsors:   University of Central Florida;   University of New Mexico;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Conditions:   Aphasia, Primary Progressive;   Anomia;   Alzheimer Disease
    Interventions:   Behavioral: Phonological;   Behavioral: Orthographic;   Behavioral: Semantic;   Behavioral: Lexical;   Behavioral: Untrained
    Sponsors:   Georgetown University;   National Institute on Deafness and Other Communication Disorders (NIDCD);   National Institute on Aging (NIA);   Johns Hopkins University
    Recruiting

  • Conditions:   Stroke;   Spinocerebellar Ataxia;   Cerebral Stroke;   Dysphagia;   Dysarthria
    Interventions:   Device: Intermittent Perturbation to Continuous Perturbation;   Device: Continuous Perturbation to Intermittent Perturbation
    Sponsors:   University of Florida;   National Institute on Deafness and Other Communication Disorders (NIDCD);   National Institutes of Health (NIH)
    Recruiting

  • Conditions:   Amyotrophic Lateral Sclerosis;   ALS-Frontotemporal Dementia;   Primary Lateral Sclerosis;   Progressive Muscular Atrophy
    Intervention:  
    Sponsors:   University of Miami;   Muscular Dystrophy Association;   National Institute of Neurological Disorders and Stroke (NINDS);   National Center for Advancing Translational Science (NCATS);   National Institutes of Health (NIH)
    Recruiting

  • Conditions:   Aphasia;   Stroke;   Stroke, Ischemic;   Aphasia, Broca;   Aphasia, Global;   Aphasia, Mixed;   Aphasia, Jargon;   Aphasia, Expressive;   Aphasia, Conduction;   Aphasia, Fluent;   Aphasia, Anomic
    Interventions:   Behavioral: Semantically focused treatment;   Behavioral: Phonologically focused treatment
    Sponsors:   University of South Carolina;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Condition:   Autism Spectrum Disorder
    Interventions:   Drug: Folinic Acid;   Other: Placebo
    Sponsors:   Emory University;   Phoenix Children's Hospital;   Harvard University;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Not yet recruiting

  • Conditions:   Rare Disorders;   Undiagnosed Disorders;   Disorders of Unknown Prevalence;   Cornelia De Lange Syndrome;   Prenatal Benign Hypophosphatasia;   Perinatal Lethal Hypophosphatasia;   Odontohypophosphatasia;   Adult Hypophosphatasia;   Childhood-onset Hypophosphatasia;   Infantile Hypophosphatasia;   Hypophosphatasia;   Kabuki Syndrome;   Bohring-Opitz Syndrome;   Narcolepsy Without Cataplexy;   Narcolepsy-cataplexy;   Hypersomnolence Disorder;   Idiopathic Hypersomnia Without Long Sleep Time;   Idiopathic Hypersomnia With Long Sleep Time;   Idiopathic Hypersomnia;   Kleine-Levin Syndrome;   Kawasaki Disease;   Leiomyosarcoma;   Leiomyosarcoma of the Corpus Uteri;   Leiomyosarcoma of the Cervix Uteri;   Leiomyosarcoma of Small Intestine;   Acquired Myasthenia Gravis;   Addison Disease;   Hyperacusis (Hyperacousis);   Juvenile Myasthenia Gravis;   Transient Neonatal Myasthenia Gravis;   Williams Syndrome;   Lyme Disease;   Myasthenia Gravis;   Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome);   Isolated Klippel-Feil Syndrome;   Frasier Syndrome;   Denys-Drash Syndrome;   Beckwith-Wiedemann Syndrome;   Emanuel Syndrome;   Isolated Aniridia;   Beckwith-Wiedemann Syndrome Due to Paternal Uniparental Disomy of Chromosome 11;   Beckwith-Wiedemann Syndrome Due to Imprinting Defect of 11p15;   Beckwith-Wiedemann Syndrome Due to 11p15 Translocation/Inversion;   Beckwith-Wiedemann Syndrome Due to 11p15 Microduplication;   Beckwith-Wiedemann Syndrome Due to 11p15 Microdeletion;   Axenfeld-Rieger Syndrome;   Aniridia-intellectual Disability Syndrome;   Aniridia - Renal Agenesis - Psychomotor Retardation;   Aniridia - Ptosis - Intellectual Disability - Familial Obesity;   Aniridia - Cerebellar Ataxia - Intellectual Disability;   Aniridia - Absent Patella;   Aniridia;   Peters Anomaly - Cataract;   Peters Anomaly;   Potocki-Shaffer Syndrome;   Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11;   Silver-Russell Syndrome Due to Imprinting Defect of 11p15;   Silver-Russell Syndrome Due to 11p15 Microduplication;   Syndromic Aniridia;   WAGR Syndrome;   Wolf-Hirschhorn Syndrome;   4p16.3 Microduplication Syndrome;   4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome;   Autosomal Recessive Stickler Syndrome;   Stickler Syndrome Type 2;   Stickler Syndrome Type 1;   Stickler Syndrome;   Mucolipidosis Type 4;   X-linked Spinocerebellar Ataxia Type 4;   X-linked Spinocerebellar Ataxia Type 3;   X-linked Intellectual Disability - Ataxia - Apraxia;   X-linked Progressive Cerebellar Ataxia;   X-linked Non Progressive Cerebellar Ataxia;   X-linked Cerebellar Ataxia;   Vitamin B12 Deficiency Ataxia;   Toxic Exposure Ataxia;   Unclassified Autosomal Dominant Spinocerebellar Ataxia;   Thyroid Antibody Ataxia;   Sporadic Adult-onset Ataxia of Unknown Etiology;   Spinocerebellar Ataxia With Oculomotor Anomaly;   Spinocerebellar Ataxia With Epilepsy;   Spinocerebellar Ataxia With Axonal Neuropathy Type 2;   Spinocerebellar Ataxia Type 8;   Spinocerebellar Ataxia Type 7;   Spinocerebellar Ataxia Type 6;   Spinocerebellar Ataxia Type 5;   Spinocerebellar Ataxia Type 4;   Spinocerebellar Ataxia Type 37;   Spinocerebellar Ataxia Type 36;   Spinocerebellar Ataxia Type 35;   Spinocerebellar Ataxia Type 34;   Spinocerebellar Ataxia Type 32;   Spinocerebellar Ataxia Type 31;   Spinocerebellar Ataxia Type 30;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 29;   Spinocerebellar Ataxia Type 28;   Spinocerebellar Ataxia Type 27;   Spinocerebellar Ataxia Type 26;   Spinocerebellar Ataxia Type 25;   Spinocerebellar Ataxia Type 23;   Spinocerebellar Ataxia Type 22;   Spinocerebellar Ataxia Type 21;   Spinocerebellar Ataxia Type 20;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 19/22;   Spinocerebellar Ataxia Type 18;   Spinocerebellar Ataxia Type 17;   Spinocerebellar Ataxia Type 16;   Spinocerebellar Ataxia Type 15/16;   Spinocerebellar Ataxia Type 14;   Spinocerebellar Ataxia Type 13;   Spinocerebellar Ataxia Type 12;   Spinocerebellar Ataxia Type 11;   Spinocerebellar Ataxia Type 10;   Spinocerebellar Ataxia Type 1 With Axonal Neuropathy;   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia - Unknown;   Spinocerebellar Ataxia - Dysmorphism;   Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Spectrin-associated Autosomal Recessive Cerebellar Ataxia;   Spasticity-ataxia-gait Anomalies Syndrome;   Spastic Ataxia With Congenital Miosis;   Spastic Ataxia - Corneal Dystrophy;   Spastic Ataxia;   Rare Hereditary Ataxia;   Rare Ataxia;   Recessive Mitochondrial Ataxia Syndrome;   Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Posterior Column Ataxia - Retinitis Pigmentosa;   Post-Stroke Ataxia;   Post-Head Injury Ataxia;   Post Vaccination Ataxia;   Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract;   Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus;   Non-progressive Cerebellar Ataxia With Intellectual Disability;   Non-hereditary Degenerative Ataxia;   Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity;   Olivopontocerebellar Atrophy - Deafness;   NARP Syndrome;   Myoclonus - Cerebellar Ataxia - Deafness;   Multiple System Atrophy, Parkinsonian Type;   Multiple System Atrophy, Cerebellar Type;   Multiple System Atrophy;   Maternally-inherited Leigh Syndrome;   Machado-Joseph Disease Type 3;   Machado-Joseph Disease Type 2;   Machado-Joseph Disease Type 1;   Lethal Ataxia With Deafness and Optic Atrophy;   Leigh Syndrome;   Leukoencephalopathy With Mild Cerebellar Ataxia and White Matter Edema;   Leukoencephalopathy - Ataxia - Hypodontia - Hypomyelination;   Leigh Syndrome With Nephrotic Syndrome;   Leigh Syndrome With Leukodystrophy;   Leigh Syndrome With Cardiomyopathy;   Late-onset Ataxia With Dementia;   Intellectual Disability-hyperkinetic Movement-truncal Ataxia Syndrome;   Infection or Post Infection Ataxia;   Infantile-onset Autosomal Recessive Nonprogressive Cerebellar Ataxia;   Infantile Onset Spinocerebellar Ataxia;   GAD Ataxia;   Hereditary Episodic Ataxia;   Gliadin/Gluten Ataxia;   Friedreich Ataxia;   Fragile X-associated Tremor/Ataxia Syndrome;   Familial Paroxysmal Ataxia;   Exposure to Medications Ataxia;   Episodic Ataxia With Slurred Speech;   Episodic Ataxia Unknown Type;   Episodic Ataxia Type 7;   Episodic Ataxia Type 6;   Episodic Ataxia Type 5;   Episodic Ataxia Type 4;   Episodic Ataxia Type 3;   Episodic Ataxia Type 1;   Epilepsy and/or Ataxia With Myoclonus as Major Feature;   Early-onset Spastic Ataxia-neuropathy Syndrome;   Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity;   Early-onset Cerebellar Ataxia With Retained Tendon Reflexes;   Early-onset Ataxia With Dementia;   Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia;   Dilated Cardiomyopathy With Ataxia;   Cataract - Ataxia - Deafness;   Cerebellar Ataxia, Cayman Type;   Cerebellar Ataxia With Peripheral Neuropathy;   Cerebellar Ataxia - Hypogonadism;   Cerebellar Ataxia - Ectodermal Dysplasia;   Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss;   Brain Tumor Ataxia;   Brachydactyly - Nystagmus - Cerebellar Ataxia;   Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia;   Autosomal Recessive Syndromic Cerebellar Ataxia;   Autosomal Recessive Spastic Ataxia With Leukoencephalopathy;   Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay;   Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria;   Autosomal Recessive Spastic Ataxia;   Autosomal Recessive Metabolic Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine;   Autosomal Recessive Ataxia, Beauce Type;   Autosomal Recessive Ataxia Due to Ubiquinone Deficiency;   Autosomal Recessive Ataxia Due to PEX10 Deficiency;   Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia;   Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia;   Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome;   Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity;   Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency;   Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect;   Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion;   Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation;   Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness;   Autosomal Recessive Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly;   Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation;   Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy;   Autosomal Dominant Spastic Ataxia Type 1;   Autosomal Dominant Spastic Ataxia;   Autosomal Dominant Optic Atrophy;   Ataxia-telangiectasia Variant;   Ataxia-telangiectasia;   Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy;   Autosomal Dominant Cerebellar Ataxia Type 4;   Autosomal Dominant Cerebellar Ataxia Type 3;   Autosomal Dominant Cerebellar Ataxia Type 2;   Autosomal Dominant Cerebellar Ataxia Type 1;   Autosomal Dominant Cerebellar Ataxia;   Ataxia-telangiectasia-like Disorder;   Ataxia-intellectual Disability-oculomotor Apraxia-cerebellar Cysts Syndrome;   Ataxia-deafness-intellectual Disability Syndrome;   Ataxia With Vitamin E Deficiency;   Ataxia With Dementia;   Ataxia Neuropathy Spectrum;   Ataxia - Tapetoretinal Degeneration;   Ataxia - Photosensitivity - Short Stature;   Ataxia - Pancytopenia;   Ataxia - Oculomotor Apraxia Type 1;   Ataxia - Hypogonadism - Choroidal Dystrophy;   Ataxia - Other;   Ataxia - Genetic Diagnosis - Unknown;   Acquired Ataxia;   Adult-onset Autosomal Recessive Cerebellar Ataxia;   Alcohol Related Ataxia;   Multiple Endocrine Neoplasia;   Multiple Endocrine Neoplasia Type II;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Multiple Endocrine Neoplasia, Type IV;   Multiple Endocrine Neoplasia, Type 3;   Multiple Endocrine Neoplasia (MEN) Syndrome;   Multiple Endocrine Neoplasia Type 2B;   Multiple Endocrine Neoplasia Type 2A;   Atypical Hemolytic Uremic Syndrome;   Atypical HUS;   Wiedemann-Steiner Syndrome;   Breast Implant-Associated Anaplastic Large Cell Lymphoma;   Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA);   Hemophagocytic Lymphohistiocytosis;   Behcet's Disease;   Alagille Syndrome;   Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD);   Lowe Syndrome;   Pitt Hopkins Syndrome;   1p36 Deletion Syndrome;   Jansen Type Metaphyseal Chondrodysplasia;   Cockayne Syndrome;   Chronic Recurrent Multifocal Osteomyelitis;   CRMO;   Malan Syndrome;   Hereditary Sensory and Autonomic Neuropathy Type Ie
    Intervention:  
    Sponsors:   Sanford Health;   National Ataxia Foundation;   International WAGR Syndrome Association;   4p- Support Group;   ML4 Foundation;   Cornelia de Lange Syndrome Foundation;   Stickler Involved People;   Kawasaki Disease Foundation;   Klippel-Feil Syndrome Alliance;   Klippel-Feil Syndrome Freedom;   Hyperacusis Research Limited;   Hypersomnia Foundation;   Kabuki Syndrome Network;   Kleine-Levin Syndrome Foundation;   Leiomyosarcoma Direct Research Foundation;   Marinesco-Sjogren Syndrome Support Group;   Mucolipidosis Type IV (ML4) Foundation;   People with Narcolepsy 4 People with Narcolepsy (PWN4PWN);   Soft Bones Incorporated;   American Multiple Endocrine Neoplasia Support;   Atypical Hemolytic Uremic Syndrome Foundation;   All Things Kabuki;   Wiedemann-Steiner Syndrome Foundation;   Breast Implant Victim Advocates;   PROS Foundation;   American Behcet's Disease Association
    Recruiting

  • Condition:   Neimann-Pick Disease, Type C
    Intervention:  
    Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Condition:   Stuttering
    Intervention:  
    Sponsor:   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Conditions:   Corticobasal Degeneration (CBD);   Corticobasal Syndrome (CBS);   Cortical-basal Ganglionic Degeneration (CBGD);   Progressive Supranuclear Palsy (PSP);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   Oligosymptomatic/Variant Progressive Supranuclear Palsy (o/vPSP)
    Intervention:   Other: Observational Study
    Sponsors:   University of California, San Francisco;   National Institutes of Health (NIH);   National Institute on Aging (NIA)
    Recruiting

  • Condition:   Autism Spectrum Disorder
    Interventions:   Behavioral: Social Communication Growth Charts (SCGC);   Behavioral: Parent-Implemented (P-I) Condition;   Behavioral: Clinician-Implemented (C-I) Condition
    Sponsor:   Emory University
    Recruiting

  • Conditions:   Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   Primary Lateral Sclerosis;   Hereditary Spastic Paraplegia;   Progressive Muscular Atrophy;   Multisystem Proteinopathy
    Intervention:  
    Sponsors:   University of Miami;   National Institute of Neurological Disorders and Stroke (NINDS);   National Center for Advancing Translational Science (NCATS);   St. Jude Children's Research Hospital;   ALS Association
    Recruiting

  • Conditions:   FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
    Intervention:  
    Sponsors:   University of California, San Francisco;   National Center for Advancing Translational Science (NCATS);   National Institute of Neurological Disorders and Stroke (NINDS);   The Bluefield Project;   Tau Consortium
    Recruiting

  • Condition:   Frontotemporal Dementia
    Intervention:   Drug: Syntocinon
    Sponsors:   Lawson Health Research Institute;   Weston Brain Institute;   Canadian Institutes of Health Research (CIHR);   Berry Consultants
    Recruiting

  • Conditions:   Healthy;   Frontotemporal Dementia
    Interventions:   Biological: AL001;   Other: Placebo
    Sponsor:   Alector Inc.
    Recruiting

  • Condition:   Familial Frontotemporal Dementia
    Intervention:  
    Sponsors:   Mayo Clinic;   National Institute on Aging (NIA);   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting

  • Condition:   Autism Spectrum Disorder
    Intervention:   Behavioral: ISC+PRT Intervention
    Sponsors:   Hugo W. Moser Research Institute at Kennedy Krieger, Inc.;   U.S. Department of Education
    Recruiting

  • Conditions:   Depressive Disorder;   Anxiety Disorders;   Bipolar Affective Disorder
    Interventions:   Behavioral: Augmented Care: Electronic media dashboard;   Behavioral: Treatment as Usual
    Sponsors:   Johns Hopkins University;   Once Upon a Time Foundation
    Recruiting

  • Condition:   Autism Spectrum Disorder
    Intervention:   Behavioral: J-EMT for Toddlers with Autism
    Sponsors:   Vanderbilt University;   Northwestern University
    Recruiting

  • Condition:   Orthopedic Disorder
    Intervention:   Other: Patient Gateway
    Sponsor:   Massachusetts General Hospital
    Recruiting

  • Condition:   Autism Spectrum Disorders
    Intervention:   Procedure: Transcranial Direct Current Stimulation (tDCS)
    Sponsor:   Johns Hopkins University
    Recruiting


PaidClinicalTrials.orgPaidClinicalTrials.org